Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aziz Zaanan

Showing results (1-10 of 137) with videos related to

Pageof 14
Sort By:
Bulletin Du Cancer|September 2, 2022
[Immunotherapy in advanced gastric cancer]Aziz Zaanan
Bulletin Du Cancer|May 21, 2024
[Tislelizumab in second line treatment for advanced oesophageal squamous cell carcinoma after previous treatment with platinum-based therapy]Jeanne Duval, Aziz Zaanan
Bulletin Du Cancer|December 12, 2018
[Predictive and prognostic value of MSI phenotype in adjuvant colon cancer: Who and how to treat?]Aziz Zaanan, Julien Taieb
Bulletin Du Cancer|May 19, 2023
[New drug approval: Trastuzumab-deruxtecan in HER2 positive advanced gastric or gastroesophageal junction cancer after previous treatment with trastuzumab]Jeanne Duval, Aziz Zaanan
Bulletin Du Cancer|March 8, 2024
[Pembrolizumab+chemotherapy as first-line treatment in patients with HER2 negative advanced oesogastric adenocarcinoma]Martin Duval, Aziz Zaanan
Translational Gastroenterology and Hepatology|March 12, 2019
How to better select patients with advanced gastric cancer for immunotherapyAziz Zaanan, Julien Taieb
Cancers|June 24, 2022
Localized Small Bowel Adenocarcinoma Management: Evidence SummaryAnthony Turpin, Mehdi El Amrani, Aziz Zaanan
Current Treatment Options in Oncology|June 3, 2015
Microsatellite instability testing and its role in the management of colorectal cancerHisato Kawakami, Aziz Zaanan, Frank A Sinicrope
Cancers|March 10, 2022
Therapeutic Strategies for Patients with Advanced Small Bowel Adenocarcinoma: Current Knowledge and PerspectivesEmilie Moati, Michael J Overman, Aziz Zaanan
Bulletin Du Cancer|January 22, 2014
[MET signalling pathway and its therapeutic implications in gastrointestinal cancers]Aziz Zaanan, Pierre Laurent-Puig, Julien Taieb
Pageof 14

Showing results (1-10 of 137) with videos related to

Sort By:
Pageof 14
Bulletin Du Cancer|September 2, 2022
[Immunotherapy in advanced gastric cancer]Aziz Zaanan
Bulletin Du Cancer|May 21, 2024
[Tislelizumab in second line treatment for advanced oesophageal squamous cell carcinoma after previous treatment with platinum-based therapy]Jeanne Duval, Aziz Zaanan
Bulletin Du Cancer|December 12, 2018
[Predictive and prognostic value of MSI phenotype in adjuvant colon cancer: Who and how to treat?]Aziz Zaanan, Julien Taieb
Bulletin Du Cancer|May 19, 2023
[New drug approval: Trastuzumab-deruxtecan in HER2 positive advanced gastric or gastroesophageal junction cancer after previous treatment with trastuzumab]Jeanne Duval, Aziz Zaanan
Bulletin Du Cancer|March 8, 2024
[Pembrolizumab+chemotherapy as first-line treatment in patients with HER2 negative advanced oesogastric adenocarcinoma]Martin Duval, Aziz Zaanan
Translational Gastroenterology and Hepatology|March 12, 2019
How to better select patients with advanced gastric cancer for immunotherapyAziz Zaanan, Julien Taieb
Cancers|June 24, 2022
Localized Small Bowel Adenocarcinoma Management: Evidence SummaryAnthony Turpin, Mehdi El Amrani, Aziz Zaanan
Current Treatment Options in Oncology|June 3, 2015
Microsatellite instability testing and its role in the management of colorectal cancerHisato Kawakami, Aziz Zaanan, Frank A Sinicrope
Cancers|March 10, 2022
Therapeutic Strategies for Patients with Advanced Small Bowel Adenocarcinoma: Current Knowledge and PerspectivesEmilie Moati, Michael J Overman, Aziz Zaanan
Bulletin Du Cancer|January 22, 2014
[MET signalling pathway and its therapeutic implications in gastrointestinal cancers]Aziz Zaanan, Pierre Laurent-Puig, Julien Taieb
Pageof 14